147 related articles for article (PubMed ID: 35954320)
21. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.
Sauer R; Liersch T; Merkel S; Fietkau R; Hohenberger W; Hess C; Becker H; Raab HR; Villanueva MT; Witzigmann H; Wittekind C; Beissbarth T; Rödel C
J Clin Oncol; 2012 Jun; 30(16):1926-33. PubMed ID: 22529255
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94).
Sauer R; Fietkau R; Wittekind C; Martus P; Rödel C; Hohenberger W; Jatzko G; Sabitzer H; Karstens JH; Becker H; Hess C; Raab R
Strahlenther Onkol; 2001 Apr; 177(4):173-81. PubMed ID: 11370551
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94.
Sauer R; Fietkau R; Wittekind C; Rödel C; Martus P; Hohenberger W; Tschmelitsch J; Sabitzer H; Karstens JH; Becker H; Hess C; Raab R;
Colorectal Dis; 2003 Sep; 5(5):406-15. PubMed ID: 12925071
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Impact of the Neoadjuvant Rectal Score as Compared With the Tumor Regression Grade and Yield Pathologic TNM Stage in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy.
Baek JH; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Kim JG
In Vivo; 2020; 34(4):1993-1999. PubMed ID: 32606172
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of Restaging Pelvis Magnetic Resonance Imaging After Neoadjuvant Concurrent Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
Fahmawi Y; Smith C; Grimm L; Khullar S; Rider P; Hunter J; Iliff G; Mneimneh W; Roveda K; Wang B; Prodduturvar P; Alkharabsheh O; McCormick B; Mizrahi M; Khushman M
Clin Colorectal Cancer; 2020 Dec; 19(4):e281-e287. PubMed ID: 32694005
[TBL] [Abstract][Full Text] [Related]
26. Downstage migration after neoadjuvant chemoradiotherapy for rectal cancer: the reverse of the Will Rogers phenomenon?
Fokas E; Liersch T; Fietkau R; Hohenberger W; Hess C; Becker H; Sauer R; Wittekind C; Rödel C
Cancer; 2015 Jun; 121(11):1724-7. PubMed ID: 25611452
[TBL] [Abstract][Full Text] [Related]
27. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.
Abdul-Jalil KI; Sheehan KM; Kehoe J; Cummins R; O'Grady A; McNamara DA; Deasy J; Breathnach O; Grogan L; O'Neill BD; Faul C; Parker I; Kay EW; Hennessy BT; Gillen P
Colorectal Dis; 2014 Jan; 16(1):O16-25. PubMed ID: 24119076
[TBL] [Abstract][Full Text] [Related]
28. Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94.
Fietkau R; Rödel C; Hohenberger W; Raab R; Hess C; Liersch T; Becker H; Wittekind C; Hutter M; Hager E; Karstens J; Ewald H; Christen N; Jagoditsch M; Martus P; Sauer R;
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1008-19. PubMed ID: 17197130
[TBL] [Abstract][Full Text] [Related]
29. ypTNM category combined with AJCC tumor regression grade for screening patients with the worst prognosis after neoadjuvant chemoradiation therapy for locally advanced rectal cancer.
Wei J; Huang R; Guo S; Zhang X; Xi S; Wang Q; Chang H; Wang X; Xiao W; Zeng Z; Gao Y
Cancer Manag Res; 2018; 10():5219-5225. PubMed ID: 30464619
[TBL] [Abstract][Full Text] [Related]
30. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.
Rödel C; Liersch T; Becker H; Fietkau R; Hohenberger W; Hothorn T; Graeven U; Arnold D; Lang-Welzenbach M; Raab HR; Sülberg H; Wittekind C; Potapov S; Staib L; Hess C; Weigang-Köhler K; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R;
Lancet Oncol; 2012 Jul; 13(7):679-87. PubMed ID: 22627104
[TBL] [Abstract][Full Text] [Related]
31. Pathologic complete response and disease-free survival are not surrogate endpoints for 5-year survival in rectal cancer: an analysis of 22 randomized trials.
Petrelli F; Borgonovo K; Cabiddu M; Ghilardi M; Lonati V; Barni S
J Gastrointest Oncol; 2017 Feb; 8(1):39-48. PubMed ID: 28280607
[TBL] [Abstract][Full Text] [Related]
32. Importance of the neoadjuvant rectal (NAR) score to the outcome of neoadjuvant chemotherapy alone for locally advanced rectal cancer.
Mukai T; Uehara K; Aiba T; Ogura A; Tsuzuki T; Tanaka A; Sando M; Ohara N; Sato Y; Hattori N; Nakayama G; Kodera Y; Nagino M
Surg Today; 2020 Aug; 50(8):912-919. PubMed ID: 31989238
[TBL] [Abstract][Full Text] [Related]
33. Can tumor regression grade influence survival outcome in ypT3 rectal cancer?
Shen L; Wang L; Li G; Zhang H; Liang L; Fan M; Wu Y; Deng W; Sheng W; Zhu J; Zhang Z
Clin Transl Oncol; 2016 Jul; 18(7):693-9. PubMed ID: 26527031
[TBL] [Abstract][Full Text] [Related]
34. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
Sun R; Cong L; Qiu HZ; Lin GL; Wu B; Niu BZ; Sun XY; Zhou JL; Xu L; Lu JY; Xiao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):522-530. PubMed ID: 35754217
[No Abstract] [Full Text] [Related]
35. Tumor regression grading after preoperative hyperfractionated radiotherapy/chemoradiotherapy for locally advanced rectal cancers: interim analysis of phase III clinical study.
Idasiak A; Galwas-Kliber K; Rajczykowski M; Dębosz-Suwińska I; Zeman M; Stobiecka E; Mrochem-Kwarciak J; Suwiński R
Neoplasma; 2021 May; 68(3):631-637. PubMed ID: 33618522
[TBL] [Abstract][Full Text] [Related]
36. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
37. Prognostic Significance of Neoadjuvant Rectal Scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer.
Huang WS; Kuan FC; Lin MH; Chen MF; Chen WC
Ann Surg Oncol; 2020 Oct; 27(11):4309-4318. PubMed ID: 32794029
[TBL] [Abstract][Full Text] [Related]
38. Prognostic and Predictive Value of NAR Score in Gastric Cancer.
Ucar G; Acikgoz Y; Ergun Y; Eren T; Dirikoc M; Esen SA; Yazıcı O; Uncu D; Ozdemir NY
J Gastrointest Cancer; 2021 Sep; 52(3):1054-1060. PubMed ID: 33064272
[TBL] [Abstract][Full Text] [Related]
39. Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data.
Li JY; Huang XZ; Gao P; Song YX; Chen XW; Lv XE; Fu Y; Xiao Q; Ye SY; Wang ZN
BMC Cancer; 2021 Nov; 21(1):1214. PubMed ID: 34773999
[TBL] [Abstract][Full Text] [Related]
40. Pretreatment CT and PET radiomics predicting rectal cancer patients in response to neoadjuvant chemoradiotherapy.
Yuan Z; Frazer M; Rishi A; Latifi K; Tomaszewski MR; Moros EG; Feygelman V; Felder S; Sanchez J; Dessureault S; Imanirad I; Kim RD; Harrison LB; Hoffe SE; Zhang GG; Frakes JM
Rep Pract Oncol Radiother; 2021; 26(1):29-34. PubMed ID: 33948299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
